Liquid Biopsies – News and Features

Company has been awarded license to store and research human tissue samples by the Human Tissue Authority.

Transgenomic, Inc. has been awarded a $100,000 Small Business Technology Transfer Program Phase I Grant by the NIH’s National Center For Advancing Translational Sciences.

Net sales for the second quarter of 2012 were $9.1 million compared with $7.7 million for the same period in 2011.

Multi-national consortium receives €6 million EU grant.

Geometrically Enhanced Differential Immunocapture chip identify and collect cancer cells from a patient's bloodstream.

Collaboration and licensing agreement to validate and develop new oncology biomarker tests.

Affymetrix releases first circulating tumour cell platform technology for 4-color RNA-ISH.

Combination of ScreenCell’s isolation devices and Affymetrix’ QuantiGene® ViewRNA ISH technology enables easy, accessible, sensitive, multiplex, low-cost system to enumerate and characterize CTCs and other rare cells.

Company to present additional Harmony(TM) Prenatal Test data at the 2012 American College of Medical Genetics Annual Clinical Genetics Meeting.

This study uses an in vitro BC gene amplification model to identify when a CNV is too small to be measured by qPCR and dPCR. Subsequently, we developed a model, based on the Poisson and binomial distributions, to determine the variance inherent in dPCR.